Candidemia in pediatric outpatients receiving home total parenteral nutrition

M V Cano1, J F Perz, A S Craig

  • 1Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. mcano@cdc.gov

Medical Mycology
|July 14, 2005
PubMed

Insights

Pediatric patients on home total parenteral nutrition (TPN) had a high rate of candidemia, particularly Candida parapsilosis. Caregivers and patients frequently harbored Candida, highlighting infection control challenges in home care.

Area of Science:

  • Infectious Diseases
  • Pediatric Medicine
  • Clinical Microbiology

Background:

  • Increased incidence of candidemia in pediatric outpatients receiving total parenteral nutrition (TPN).
  • Candida parapsilosis identified as a causative agent in several cases.

Purpose of the Study:

  • To investigate the incidence and potential sources of candidemia in pediatric patients on home TPN.
  • To assess the role of healthcare providers and family members in candidemia transmission.

Main Methods:

  • Cohort study of pediatric outpatients receiving home TPN between January and June 1999.
  • Microbiological cultures (including hand cultures) and molecular typing (karyotyping, RAPD) of Candida isolates.
  • Statistical analysis to identify risk factors for candidemia.

Main Results:

  • Five of 13 pediatric patients on home TPN developed candidemia; three were caused by Candida parapsilosis.
  • Underlying hematologic disease and previous fungemia were associated with candidemia (P = 0.02).
  • Candida spp. were frequently isolated from hand cultures of patients (40%) and caregivers (82%), including C. parapsilosis from five caregivers.

Conclusions:

  • Home TPN care presents significant infection control challenges.
  • Close contact with caregivers and environmental contamination may contribute to candidemia in pediatric patients.
  • Enhanced follow-up and coordination of home TPN therapy are crucial for pediatric patients.

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...